NCT06187194View on ClinicalTrials.gov

Efficacy and Safety of Irreversible Electroporation for Chronic Symptomatic Tonsillar Hypertrophy Treatment

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

April 30, 2026

Conditions

Tonsillar Hypertrophy

Interventions

DEVICE

IRE System

Irreversible Electroporation (IRE) System for Tonsil Reduction for The Treatment of Chronic Symptomatic Tonsillar Hypertrophy

Trial Locations (1)

Unknown

Saint Mary Hospital, Bucharest

All Listed Sponsors

lead

ENTire Medical Ltd.

INDUSTRY

NCT06187194 - Efficacy and Safety of Irreversible Electroporation for Chronic Symptomatic Tonsillar Hypertrophy Treatment | Biotech Hunter | Biotech Hunter